|
Halothane | CAS 151-67-7 | ||
CF3CHBrCl | RTECS KH6550000 | ||
Synonyms & Trade Names 1-Bromo-1-chloro-2,2,2-trifluoroethane; 2-Bromo-2-chloro-1,1,1-trifluoroethane; 1,1,1-Trifluoro-2-bromo-2-chloroethane; 2,2,2-Trifluoro-1-bromo-1-chloroethane |
DOT ID & Guide |
Exposure Limits |
NIOSH REL*: C 2 ppm (16.2 mg/m3) [60-minute] [*Note: REL for exposure to waste anesthetic gas.] | ||
OSHA PEL: none | |||
IDLH N.D. | Conversion 1 ppm = 8.07 mg/m3 |
Physical Description Clear, colorless liquid with a sweetish, pleasant odor. [inhalation anesthetic] |
|||
MW: 197.4 |
BP: 122°F |
FRZ: -180°F |
Sol: 0.3% |
VP: 243 mmHg |
IP: ? |
|
Sp.Gr: 1.87 |
Fl.P: NA |
UEL: NA |
LEL: NA |
|
Noncombustible Liquid | |||
Incompatibilities & Reactivities May attack rubber & some plastics; sensitive to light. [Note: Light causes decomposition. May be stabilized with 0.01% thymol.] |
Measurement Methods OSHA 29 |
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: No recommendation Provide: Eyewash |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash promptly Breathing: Respiratory support Swallow: Medical attention immediately |
Respirator Recommendations To be added later | |
Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
Symptoms Irritation eyes, skin, respiratory system; confusion, drowsiness, dizziness, nausea, analgesia, anesthesia; cardiac arrhythmias; liver, kidney damage; decreased audio-visual performance; in animals: reproductive effects | |
Target Organs
Eyes, skin, respiratory system, cardiovascular system, central nervous system, liver, kidneys, reproductive system |
See also: INTRODUCTION |